Results of our in vitro analysis in the lung cancer cell line (H1299) and healthy fibroblasts (WI-38) indicated that the tested variant is associated with lower activity of NF-κB signaling, an important cancer signaling pathway that plays a crucial role in the induction of inflammatory response in lung cancer [27]. The gene discussed is NFKB1; the disease is lung carcinoma.